Silo Pharma, Inc.
SILO
$1.06
-$0.0148-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.39M | -3.78M | -3.51M | -3.60M | -3.70M |
| Total Depreciation and Amortization | 6.20K | 3.10K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.10K | 68.10K | 96.70K | 139.10K | 176.90K |
| Change in Net Operating Assets | 551.70K | -114.20K | -133.70K | 86.90K | 299.30K |
| Cash from Operations | -3.83M | -3.83M | -3.55M | -3.37M | -3.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 973.80K | 5.44M | 6.74M | 1.96M | -4.15M |
| Cash from Investing | 973.80K | 5.44M | 6.74M | 1.96M | -4.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.41M | 3.41M | 1.67M | -- | -- |
| Repurchase of Common Stock | -173.20K | -367.60K | -513.30K | -586.60K | -471.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.24M | 3.05M | 1.16M | -586.60K | -471.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 381.50K | 4.66M | 4.35M | -2.00M | -7.84M |